BioCentury

1:23 AM GMT, Nov 3, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Amylin, Takeda in obesity deal

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) partnered with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) to co-develop and commercialize

Read the full 152 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.